{"id":12462,"date":"2015-05-13T19:24:31","date_gmt":"2015-05-13T19:24:31","guid":{"rendered":"http:\/\/healthmedicinet.com\/news\/when-it-comes-to-testosterone-more-isnt-always-better\/"},"modified":"2015-05-13T19:24:31","modified_gmt":"2015-05-13T19:24:31","slug":"when-it-comes-to-testosterone-more-isnt-always-better","status":"publish","type":"post","link":"http:\/\/healthmedicinet.com\/news\/when-it-comes-to-testosterone-more-isnt-always-better\/","title":{"rendered":"When it comes to testosterone, more isn\u00e2\u20ac\u2122t always better"},"content":{"rendered":"<p>Benign prostatic hyperplasia (BPH) \u00e2\u20ac\u201d or, simply, prostate enlargement \u00e2\u20ac\u201d is one of the most common diseases of aging among men in the United States. In fact, by the time they hit 80 or above, upwards of 90 percent of all men in the U.S. experience some degree of prostate enlargement. And of those, 40 percent require medical treatment.<\/p>\n<p>Despite the fact that the disease impacts so many people and carries with it a huge price tag \u00e2\u20ac\u201d estimated at tens of billions of dollars per year in medical expenses and lost wages, among other costs \u00e2\u20ac\u201d the factors that contribute to BPH have yet to be positively identified.  <\/p>\n<p>However, a new study conducted by UC Santa Barbara anthropologists suggests that the hormone testosterone \u00e2\u20ac\u201d specifically, an unnatural overabundance thereof \u00e2\u20ac\u201d may be a prime culprit. Building on previous research they conducted with the Tsimane, an isolated indigenous population in central Bolivia, Benjamin Trumble and Michael Gurven examined the prevalence of BPH among a group of approximately 350 adult males.<\/p>\n<p>Within that group, advanced cases of prostate enlargement were practically non-existent. As a correlating factor, the Tsimane also have relatively low levels of testosterone that remain constant over their lives.<\/p>\n<p>\u00e2\u20ac\u0153Abdominal ultrasounds show they have significantly smaller prostates \u00e2\u20ac\u201d an age-adjusted 62 percent smaller prostate size \u00e2\u20ac\u201d as compared to men in the U.S.,\u00e2\u20ac\u009d said Trumble, a postdoctoral scholar at UCSB and the paper\u00e2\u20ac\u2122s lead author. \u00e2\u20ac\u0153BPH is not inevitable for Tsimane men.\u00e2\u20ac\u009d The researchers\u00e2\u20ac\u2122 work appears in the <i>Journals of Gerontology: Medical Sciences<\/i>.<\/p>\n<p>\u00e2\u20ac\u0153We also know testosterone and androgens are involved because of studies showing that eunuchs and people who don\u00e2\u20ac\u2122t have testes have very low rates of BPH,\u00e2\u20ac\u009d Trumble added. \u00e2\u20ac\u0153Some of the best pharmacological BPH and prostate cancer treatments involve reducing androgen levels. We also know from our own previous research that Tsimane have relatively low levels of testosterone \u00e2\u20ac\u201d about 30 percent lower than age-matched U.S. males \u00e2\u20ac\u201d and they have very low rates of obesity and hypertension and heart disease and all the other diseases of acculturation, including metabolic disease.\u00e2\u20ac\u009d<\/p>\n<p>Despite having low testosterone overall, Tsimane men with higher testosterone levels (but still significantly lower than those of men in industrial populations) have larger prostates. According to the researchers, this has important implications for the millions of men who use testosterone supplements to counteract low testosterone. They may be putting themselves at risk for prostate enlargement.<\/p>\n<p>\u00e2\u20ac\u0153Basically, these guys taking testosterone replacement therapies are entering themselves into an uncontrolled experiment,\u00e2\u20ac\u009d said Trumble. \u00e2\u20ac\u0153And this happened to women with estrogen replacement therapy from the 1980s to the early 2000s. And then the Women\u00e2\u20ac\u2122s Health Initiative study came out and showed that all these women were putting themselves at risk for breast and other cancers.\u00e2\u20ac\u009d<\/p>\n<p>Although this particular study did not test for prostate cancer, other studies have shown that population differences in testosterone impact prostate cancer risk as well, according to Trumble. \u00e2\u20ac\u0153Populations with higher testosterone exposure appear to have higher rates of prostate cancer,\u00e2\u20ac\u009d he said. \u00e2\u20ac\u0153And similar to those for BPH, many of the pharmacological treatments for prostate cancer block androgens.\u00e2\u20ac\u009d<\/p>\n<p>The researchers\u00e2\u20ac\u2122 findings raise questions about the health benefits \u00e2\u20ac\u201d and risks \u00e2\u20ac\u201d that come from our attempts to thwart Mother Nature. \u00e2\u20ac\u0153In American men, testosterone levels decrease with age,\u00e2\u20ac\u009d said Gurven, a professor of anthropology and senior author of the paper. Gurven also is co-director of the Tsimane Health and Life History Project, a joint effort of the University of New Mexico and UCSB. \u00e2\u20ac\u0153It\u00e2\u20ac\u2122s easy to look at that pattern and think, \u00e2\u20ac\u02dcWell, if I want to reverse the aging process, I only need to return to the high levels of testosterone of my vigorous youth.\u00e2\u20ac\u2122<\/p>\n<p>\u00e2\u20ac\u0153But there\u00e2\u20ac\u2122s probably a reason your body is producing less testosterone than it used to, and if you try to trick it and flood it with testosterone supplements, you may see some beneficial effects \u00e2\u20ac\u201d people report feeling more energized, having a stronger libido \u00e2\u20ac\u201d but at what cost?\u00e2\u20ac\u009d he continued. \u00e2\u20ac\u0153Perhaps even if you knew the costs, you\u00e2\u20ac\u2122d still make the decision to use testosterone replacement therapy and discount the risks relative to the potential gains, but understanding those risks is vital in order to make an informed decision.\u00e2\u20ac\u009d<\/p>\n<p>The bottom line: More long-term studies of testosterone replacement therapy in men are necessary to ensure its safety and efficacy.<\/p>\n<p>\u00e2\u20ac\u0153Something else we found is that even the men who did have anatomical BPH beyond a certain cutoff, the size that would require treatment in the U.S., those were exceedingly rare,\u00e2\u20ac\u009d said Trumble. \u00e2\u20ac\u0153About 50 percent of men in their 70s in the U.S. have prostates larger than 40 cubic centimeters, which is the level where they start looking at major medical interventions. For the Tsimane, less than 1 percent of all men in the study had prostates larger than 40 cubic centimeters.<\/p>\n<p>\u00e2\u20ac\u0153Not only were they smaller, but those that were relatively larger were still much smaller than what you\u00e2\u20ac\u2122d see in the U.S.,\u00e2\u20ac\u009d Trumble added, \u00e2\u20ac\u0153and smaller than what would require treatment.\u00e2\u20ac\u009d<\/p>\n<p>In addition to measuring prostate size, the researchers looked at the levels of glycated hemoglobin in the subjects\u00e2\u20ac\u2122 blood. Glycated hemoglobin \u00e2\u20ac\u201d HbA1c \u00e2\u20ac\u201d is a measure of long-term glucose exposure that in turn indicates the risk of diabetes. \u00e2\u20ac\u0153Despite having subclinical levels of HbA1c, men with higher HbA1c had larger prostates,\u00e2\u20ac\u009d said Trumble. \u00e2\u20ac\u0153Not one of the men in this study had HbA1c indicative of diabetes. These were all men with relatively low glucose levels.<\/p>\n<p>\u00e2\u20ac\u0153Among men with low testosterone and low diabetes risk, those with relatively higher testosterone or HbA1c were at higher risk of prostate enlargement,\u00e2\u20ac\u009d he said.<\/p>\n<p>But what does the health and wellness of the Tsimane, a population of hunters and forager-farmers, tell us about ourselves?<\/p>\n<p>\u00e2\u20ac\u0153The Tsimane are living under conditions that are more typical of our preindustrial past,\u00e2\u20ac\u009d explained Gurven. \u00e2\u20ac\u0153Working with populations like the Tsimane gives us a nice window into how traditional lifestyles and environments \u00e2\u20ac\u201d subsistence diet, physical activity, natural fertility, infectious exposure and kin-based social networks \u00e2\u20ac\u201d can shape health and wellbeing.\u00e2\u20ac\u009d The types of chronic diseases that afflict us today may manifest because of the relatively rapid changes in all these factors over the past several hundred years, he noted. Although gene frequencies continue to change, he said, we\u00e2\u20ac\u2122re still fundamentally \u00e2\u20ac\u0153Stone Agers in the fast lane.\u00e2\u20ac\u009d<\/p>\n<p>\u00e2\u20ac\u0153Type 2 (adult onset) diabetes is one of these illnesses that under more traditional conditions wouldn\u00e2\u20ac\u2122t be as prevalent as it is today in high-income countries, or becoming increasingly prevalent in urban areas of low-income countries,\u00e2\u20ac\u009d Gurven said. \u00e2\u20ac\u0153As groups of the Tsimane undergo change, we might very well see an increase in diabetes. Then it wouldn\u00e2\u20ac\u2122t be surprising if heart disease, BPH and other modern maladies follow suit, especially to the extent that these ailments share common causes.<\/p>\n<p>\u00e2\u20ac\u0153It\u00e2\u20ac\u2122s a great example of evolutionary medicine in which understanding our human biological history is really important in terms of the way we think about medicine,\u00e2\u20ac\u009d he added.<\/p>\n<p>In the end, the researchers argue, prostate enlargement is not necessarily an inevitable part of male aging. It is a disease that our low-pathogen, resource-abundant sedentary lifestyle is creating for us.<\/p>\n<p align=\"center\">###<\/p>\n<p>Other researchers contributing to the study include Hillard S. Kaplan of the University of New Mexico; Jonathan Stieglitz of the University of New Mexico and the Institute for Advanced Study in Toulouse, France; and Daniel Eid Rodriguez and Edhitt Cortez Linares of the Tsimane Health and Life History Project in San Borja, Bolivia.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Benign prostatic hyperplasia (BPH) \u00e2\u20ac\u201d or, simply, prostate enlargement \u00e2\u20ac\u201d is one of the most common diseases of aging among men in the United States. In fact, by the time they hit 80 or above, upwards of 90 percent of all men in the U.S. experience some degree of prostate enlargement. And of those, 40 [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-12462","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/posts\/12462","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/comments?post=12462"}],"version-history":[{"count":0,"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/posts\/12462\/revisions"}],"wp:attachment":[{"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/media?parent=12462"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/categories?post=12462"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/healthmedicinet.com\/news\/wp-json\/wp\/v2\/tags?post=12462"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}